CPC C07K 16/1275 (2013.01) [A61K 9/0019 (2013.01); A61K 39/395 (2013.01); A61K 39/39591 (2013.01); A61K 47/183 (2013.01); C07K 16/065 (2013.01); C07K 16/121 (2013.01); C07K 16/125 (2013.01); C07K 16/1232 (2013.01); C07K 16/1267 (2013.01); C07K 16/14 (2013.01); A61K 2039/507 (2013.01); C07K 1/30 (2013.01); C07K 2317/21 (2013.01); C07K 2317/76 (2013.01)] | 20 Claims |
1. A method of treatment of a patient suffering from a viral infection comprising administering an antibody preparation to said patient wherein the antibody preparation comprises immunoglobulins IgG, IgA and IgM, wherein at least 15% by weight of the total immunoglobulins are IgM, at least 5% by weight of the total immunoglobulins are IgA and at least 40% by weight of the total immunoglobulins are IgG, wherein the antibody preparation is virus safe with respect to enveloped and non-enveloped virus, has an anticomplementary activity of ≤1 CH 50/mg protein, is stable in liquid form for at least 2 years when stored at 2 to 8° C., wherein the antibody preparation comprises a protein concentration of 40 g/L to 80 g/L, and an immunoglobulin content of greater than 95% of the total protein content.
|